Johnson & Johnson Invests more than $1 Billion to Strengthen U.S. Vision Manufacturing in Jacksonville, FL

Johnson & Johnson announced a more than $1 billion investment to enhance its Vision operations in Jacksonville, Florida, focusing on scaling U.S.-based manufacturing, packaging, and distribution for ACUVUE® contact lenses. The expansion includes a new state-of-the-art distribution facility and advanced technologies to meet growing demand. The company stated the investment aims to strengthen the domestic supply chain and improve access to eye health solutions for patients in the U.S. and globally.

Construction of the new facility is underway, with plans for full operation by 2028. The investment aligns with Johnson & Johnson’s broader $55 billion U.S. commitment to manufacturing, research, and technology through early 2029. The expansion builds on the company’s $6 billion annual economic impact in Florida and supports 3,500 local employees while reinforcing regional economic growth.

Local and federal leaders praised the investment as a boost to Jacksonville’s advanced manufacturing sector and healthcare infrastructure. Mayor Donna Deegan highlighted the project as a vote of confidence in the city’s workforce and future, while U.S. Senator Rick Scott emphasized its role in strengthening America’s healthcare supply chain and reducing reliance on foreign products.

Johnson & Johnson has manufactured ACUVUE® contact lenses in Jacksonville since 1981, producing over 1.7 billion lenses annually for U.S. patients. The expansion will further solidify the region’s role in critical healthcare production, supporting jobs and economic competitiveness in Northeast Florida.